Literature DB >> 20084052

Accurate estimation of vascular endothelial growth factor levels in microsamples with a low-cost bead-based assay.

Kakarla V Chalam1, Sankarathi Balaiya, Ravi K Murthy.   

Abstract

PURPOSE: The purpose of this study was to evaluate the accuracy of measurement of a known concentration of vascular endothelial growth factor (VEGF) using cytometric bead-based assay in microsamples (50 microL) and compare it with that obtained by enzyme-linked immunosorbent assay.
METHODS: A known concentration of VEGF samples was prepared with addition of VEGF (100 pg/mL) to 1 mL of Hank balanced salt solution. This preparation was further diluted serially to 50, 25, and 12.5 pg/mL; and VEGF estimation was done on each of these samples using Luminex, a commercially available cytometric bead-based assay and enzyme-linked immunosorbent assay. The assay was replicated three times at each dilution.
RESULTS: The mean concentrations of VEGF measured using Luminex were 97.7 +/- 6.2, 47.3 +/- 8.1, 24.9 +/- 2.2, and 14.2 +/- 1.8 pg/mL at 100, 50, 25, and 12.5 pg/mL dilutions, respectively. Similarly, the mean concentrations of VEGF measured using enzyme-linked immunosorbent assay for equivalent dilutions were 100.6 +/- 24.4, 53.8 +/- 16.8, 44.8 +/- 35.5, and 14.19 +/- 0.7 pg/mL, respectively.
CONCLUSION: Bead-based assay accurately measures VEGF concentration in a microsample and has better validity and reliability as compared with enzyme-linked immunosorbent assay.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20084052     DOI: 10.1097/IAE.0b013e3181c70153

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  2 in total

1.  Freezing adversely affects measurement of vascular endothelial growth factor levels in human aqueous samples.

Authors:  Sankarathi Balaiya; Sandeep Grover; Ravi K Murthy; Kakarla V Chalam
Journal:  Clin Ophthalmol       Date:  2011-01-11

2.  Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration.

Authors:  Kakarla V Chalam; Sandeep Grover; Kumar Sambhav; Sankarathi Balaiya; Ravi K Murthy
Journal:  J Ophthalmol       Date:  2014-07-10       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.